You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Palivizumab

Showing 1 - 25 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Congenital Heart Disease in Children, RSV Trial in Istanbul (Phone call, Text message, Control)

Completed
  • Congenital Heart Disease in Children
  • RSV
  • Phone call
  • +2 more
  • Istanbul, Turkey
    Kosuyolu Heart Hospital
Mar 18, 2023

Healthy Volunteers Trial in Brisbane, Auckland, Christchurch (MB05 (Proposed palivizumab biosimilar), EU-Synagis®, US-Synagis®)

Active, not recruiting
  • Healthy Volunteers
  • MB05 (Proposed palivizumab biosimilar)
  • +2 more
  • Brisbane, Queensland, Australia
  • +2 more
Jan 16, 2023

Healthy Adult Participants Trial in London (Palivizumab, Placebo, RSV-A Memphis 37b virus)

Completed
Has Results
  • Healthy Adult Participants
  • Palivizumab
  • +2 more
  • London, United Kingdom
    hVIVO Services Limited
Sep 7, 2021

Respiratory Syncytial Virus Infections Trial in Worldwide (MEDI8897, Palivizumab)

Active, not recruiting
  • Respiratory Syncytial Virus Infections
  • Anaheim, California
  • +127 more
Aug 18, 2022

RSV Infection Trial in Worldwide (MK-1654, Palivizumab, Placebo)

Recruiting
  • RSV Infection
  • Clesrovimab
  • +2 more
  • Long Beach, California
  • +129 more
Jan 25, 2023

RSV Infection Trial in Worldwide (Nirsevimab)

Active, not recruiting
  • RSV Infection
  • Los Angeles, California
  • +27 more
Mar 18, 2022

Acute Bronchiolitis Due to Respiratory Syncytial Virus Trial in Ghent (V-306 candidate vaccine)

Completed
  • Acute Bronchiolitis Due to Respiratory Syncytial Virus
  • V-306 candidate vaccine
  • Ghent, Belgium
    Centre for Vaccinology (CEVAC)
Mar 4, 2022

Respiratory Syncytial Virus Infections Trial in United States (Saline Placebo (0.5mL injection), RSV F vaccine (0.5mL

Completed
  • Respiratory Syncytial Virus Infections
  • Saline Placebo (0.5mL injection)
  • RSV F vaccine (0.5mL injection)
  • Nampa, Idaho
  • +6 more
May 25, 2022

Respiratory Syncytial Virus Infections Trial

Completed
Has Results
  • Respiratory Syncytial Virus Infections
    • (no location specified)
    Feb 5, 2018

    Respiratory Syncytial Viruses Trial in Australia (RSV F Vaccine with Aluminum Phosphate Adjuvant, RSV F Vaccine, Matrix-M1

    Completed
    • Respiratory Syncytial Viruses
    • RSV F Vaccine with Aluminum Phosphate Adjuvant
    • +3 more
    • Sydney, New South Wales, Australia
    • +4 more
    Dec 2, 2021

    Respiratory Syncytial Virus (RSV) Trial in United States (RSV-F Vaccine, Phosphate Buffer Placebo)

    Completed
    • Respiratory Syncytial Virus (RSV)
    • RSV-F Vaccine
    • Phosphate Buffer Placebo
    • Birmingham, Alabama
    • +59 more
    Jul 15, 2022

    Acute Bronchiolitis Trial in Mardan (3% normal saline, steroid(beclomethasone dipropionate 400 µg/day) and salbutamol with 0.9%

    Completed
    • Acute Bronchiolitis
    • 3% normal saline
    • steroid(beclomethasone dipropionate 400 μg/day) and salbutamol with 0.9% normal saline
    • Mardan, Kpk, Pakistan
      Faizan Sadiq
    Nov 17, 2023

    Respiratory Syncytial Virus Infections Trial (Nirsevimab)

    Not yet recruiting
    • Respiratory Syncytial Virus Infections
    • (no location specified)
    Jun 24, 2022

    Acute Respiratory Tract Infections, Pneumonia, Respiratory Syncytial Virus (RSV) Trial in Ha Noi (0.9% NaCl physiological

    Recruiting
    • Acute Respiratory Tract Infections
    • +2 more
    • 0.9% NaCl physiological saline
    • LiveSpo Navax
    • Ha Noi, Vietnam
      The Center for Pulmonology and Respiratory Care, Vietnam Nationa
    Jul 4, 2023

    Respiratory Syncytial Virus-bronchiolitis Trial in Doha (Palivizumab, Placebo)

    Completed
    • Respiratory Syncytial Virus-bronchiolitis
    • Palivizumab
    • Placebo
    • Doha, Qatar
      Hamad Medical Corporation
    Feb 26, 2018

    Respiratory Syncytial Virus (RSV) Trial (Palivizumab)

    Completed
    Has Results
    • Respiratory Syncytial Virus (RSV)
    • Palivizumab
    • (no location specified)
    Feb 9, 2018

    Chronic Lung Disease Trial in United States (Lyophilized Palivizumab, Liquid Palivizumab)

    Completed
    Has Results
    • Chronic Lung Disease
    • Lyophilized Palivizumab
    • Liquid Palivizumab
    • Birmingham, Alabama
    • +53 more
    Apr 6, 2018

    Spinal Muscular Atrophy Trial in Columbus (AVXS-101)

    Approved for marketing
    • Spinal Muscular Atrophy
    • AVXS-101
    • Columbus, Ohio
      Nationwide Children's Hospital
    Aug 26, 2020

    Respiratory Syncytial Virus Infections Trial in Worldwide (RSV (GSK3389245A) low dose formulation vaccine, RSV (GSK3389245A)

    Completed
    Has Results
    • Respiratory Syncytial Virus Infections
    • RSV (GSK3389245A) low dose formulation vaccine
    • +3 more
    • Anaheim, California
    • +23 more
    Sep 28, 2021

    Acute Respiratory Tract Infections Trial in Hanoi (LiveSpo Navax, 0.9% NaCl physiological saline)

    Completed
    • Acute Respiratory Tract Infections
    • LiveSpo Navax
    • 0.9% NaCl physiological saline
    • Hanoi, Vietnam
      International Center, Vietnam National Children's Hospital
    Dec 18, 2021

    Disease Burden of RSV

    Not yet recruiting
    • RSV Acute Respiratory Infection
    • Diagnostic test and phone call
    • Diagnostic test
    • Bron, Rhone, France
      Centre d'Investigation Clinique de Lyon- Groupement Hospitalier
    Aug 17, 2022

    Upper Respiratory Tract Infections Trial run by the NIAID (10^6.3 PFU of RSV A2, 10^7 PFU of RSV A2)

    Completed
    Has Results
    • Upper Respiratory Tract Infections
    • 10^6.3 PFU of RSV A2
    • 10^7 PFU of RSV A2
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Nov 12, 2020

    Respiratory Syncytial Virus Infections Trial in Worldwide (RSV F vaccine with adjuvant, Formulation buffer)

    Completed
    • Respiratory Syncytial Virus Infections
    • RSV F vaccine with adjuvant
    • Formulation buffer
    • Birmingham, Alabama
    • +87 more
    Apr 9, 2020

    Respiratory Syncytial Virus Monoclonal Antibody Therapy

    Completed
    • Lower Respiratory Tract Infection
    • Respiratory Syncytial Virus Infections
      • Calgary, Alberta, Canada
      • +1 more
      Apr 13, 2018

      Respiratory Syncytial Virus Infections Trial in Worldwide (RSV Vaccine (GSK3003891A) formulation 1, RSV Vaccine (GSK3003891A)

      Completed
      Has Results
      • Respiratory Syncytial Virus Infections
      • RSV Vaccine (GSK3003891A) formulation 1
      • +3 more
      • Gent, Belgium
      • +7 more
      Jun 24, 2019